These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37192644)
21. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma. Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C Front Immunol; 2023; 14():1171883. PubMed ID: 37056778 [TBL] [Abstract][Full Text] [Related]
22. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma. Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T Front Immunol; 2023; 14():1230267. PubMed ID: 37600792 [TBL] [Abstract][Full Text] [Related]
23. Senescence gene expression in clear cell renal cell carcinoma: Role of tumor immune microenvironment and senescence-associated survival prediction. Wu Y; Li X Medicine (Baltimore); 2023 Oct; 102(40):e35222. PubMed ID: 37800815 [TBL] [Abstract][Full Text] [Related]
24. Construction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma. He J; Zhong Y; Sun Y; Xie C; Yu T Anal Biochem; 2022 Apr; 643():114567. PubMed ID: 35122734 [TBL] [Abstract][Full Text] [Related]
25. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma. Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J Front Immunol; 2022; 13():1021935. PubMed ID: 36248876 [TBL] [Abstract][Full Text] [Related]
26. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma. Wei K; Zhang X; Yang D PeerJ; 2023; 11():e16643. PubMed ID: 38130918 [TBL] [Abstract][Full Text] [Related]
27. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763 [TBL] [Abstract][Full Text] [Related]
28. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma. Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S Front Immunol; 2022; 13():1048204. PubMed ID: 36505496 [TBL] [Abstract][Full Text] [Related]
29. Single-Cell RNA-Seq Analysis Reveals Ferroptosis in the Tumor Microenvironment of Clear Cell Renal Cell Carcinoma. Zhang J; Deng Y; Zhang H; Zhang Z; Jin X; Xuan Y; Zhang Z; Ma X Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240436 [TBL] [Abstract][Full Text] [Related]
30. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma. Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227 [TBL] [Abstract][Full Text] [Related]
31. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
32. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma. Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357 [TBL] [Abstract][Full Text] [Related]
33. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma. Zhou S; Lu Y; Chen Y; Gan W Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108 [TBL] [Abstract][Full Text] [Related]
34. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration. Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993 [TBL] [Abstract][Full Text] [Related]
35. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
36. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma. Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824 [TBL] [Abstract][Full Text] [Related]
37. A novel coagulation-related lncRNA predicts the prognosis and immune of clear cell renal cell carcinoma. Wu W; Chang F; Zhang J; Tang S; Lv Z; Chen F Sci Rep; 2023 Sep; 13(1):16302. PubMed ID: 37770494 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm. Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223 [TBL] [Abstract][Full Text] [Related]
39. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048 [TBL] [Abstract][Full Text] [Related]
40. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry. Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]